HomeComunicação SBN

Comunicação SBN

16
fev

The New England Journal of Medicine 2019 – Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

Por: Comunicação SBN Comments are Off

16
fev

The New England Journal of Medicine 2017 – Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

Por: Comunicação SBN Comments are Off

16
fev

The New England Journal of Medicine 2001 – Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

Por: Comunicação SBN Comments are Off

16
fev

The New England Journal of Medicine 1993 – The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy

Por: Comunicação SBN Comments are Off

16
fev

The New England Journal of Medicine 2003 – The Natural History of Chronic Allograft Nephropathy

Por: Comunicação SBN Comments are Off

16
fev

The New England Journal of Medicine 2004 – Transplantation — A Medical Miracle of the 20th Century

Por: Comunicação SBN Comments are Off

16
fev

Garstang 1801 – On the orgin of Vaccine Inoculation

Por: Comunicação SBN Comments are Off

16
fev

Transplant International IS 2009 – Surgeon Yurii Voronoy (1895–1961) – a pioneer in the history of clinical transplantation: in Memoriam at the 75th Anniversary of the First Human Kidney Transplantation

Por: Comunicação SBN Comments are Off

16
fev

Urol Clin N Am 2023 – Pediatric Stone Disease Current Trends and Future Directions

Por: Comunicação SBN Comments are Off

16
fev

Acta diabet, lat. 1970 – Pancreatico-duodenal allotransplantation: experimental and clinical experience

Por: Comunicação SBN Comments are Off